# Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^

> **NCT01227980** · PHASE2 · COMPLETED · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 70 (actual)

## Conditions studied

- Alcohol-Related Disorders
- Alcohol Dependence
- Alcoholism
- Anxiety Disorder

## Interventions

- **DRUG:** Pexacerfont
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01227980
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227980, "Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01227980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*